Trial Profile
Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2021
Price :
$35
*
At a glance
- Drugs Erythropoietin (Primary)
- Indications Optic neuritis
- Focus Therapeutic Use
- Acronyms TONE
- 27 Feb 2021 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021.
- 29 Nov 2019 Status changed from active, no longer recruiting to completed.
- 05 Mar 2019 Planned End Date changed from 1 Oct 2019 to 30 May 2019.